Oral Supplement Containing Hydroxytyrosol and Punicalagin Improves Dyslipidemia in an Adult Population without Co-Adjuvant Treatment: A Randomized, Double-Blind, Controlled and Crossover Trial

Hydroxytyrosol (HT) and punicalagin (PC) exert cardioprotective and antiatherosclerotic effects. This study evaluated the effect of an oral supplement containing HT and PC (SAx) on dyslipidemia in an adult population. A randomized, double-blind, controlled, crossover trial was conducted over a 20-we...

Descripción completa

Detalles Bibliográficos
Autores principales: Quirós-Fernández, Rebeca, López-Plaza, Bricia, Bermejo, Laura M., Palma Milla, Samara, Zangara, Andrea, Candela, Carmen Gómez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103949/
https://www.ncbi.nlm.nih.gov/pubmed/35565844
http://dx.doi.org/10.3390/nu14091879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103949/
https://www.ncbi.nlm.nih.gov/pubmed/35565844
http://dx.doi.org/10.3390/nu14091879

Ejemplares similares